KRAS is among the most frequently mutated genes in cancer patients, with oncogenic mutations found in ~ 30% of lung adenocarcinomas (LUAD), ~ 95% of pancreatic ductal adenocarcinomas (PDAC), and ~ 45% of colorectal carcinomas (CRC) [10]. This evidence concerns the gene KRAS and lung adenocarcinoma.